An increasing number of patients are treated by autologous chondrocyte implantation (ACI). This study tests the hypothesis that culture within a defined chondrogenic medium containing TGF-β β β β enhances the re-expression of a chondrocytic phenotype and the subsequent production of cartilaginous extracellular matrix by human chondrocytes used in ACI. Chondrocytes surplus to clinical requirements for ACI from 24 patients were pelleted and cultured in either DMEM (Dulbecco's modified eagles medium)/ITS+Premix/TGF-β β β β1 or DMEM/10%FCS (fetal calf serum) and were subsequently analysed biochemically and morphologically.
The treatment of cartilage damage in the younger patient is a major challenge to the surgeon since articular cartilage has limited potential for intrinsic repair. 1 Two strategies have been considered for restoration of the joint surface. The first approach is to enhance the intrinsic healing capacity of both the cartilage and subchondral bone through the release of mesenchymal stem cells involving procedures such as subchondral drilling, 2 microfracture, 3 abrasion arthroplasty, 4,5 electrical 6 and laser stimulation. 7 These methods have generally led to the formation of fibrocartilage, which has limited functionality compared with hyaline articular cartilage. An alternative approach, particularly suited to the younger patient, involves the use of tissue engineering strategies to elicit a biological repair that has long-term functionality.
Autologous chondrocyte implantation (ACI) involves the harvesting of cartilage from the knee, the isolation of chondrocytes and subsequent monolayer expansion. A second operation is then performed after three or four weeks to re-implant the cells into the defect. 8 A recent development of the ACI procedure, termed matrix-induced autologous chondrocyte implantation (MACI), involves seeding the cells into a collagen membrane which is cultured in vitro for a few days prior to implantation. Success rates for ACI range from 60% to 90% depending on site and location of the cartilage defect. 8, 9 The histological appearance of hyaline cartilage is reported to correlate with successful clinical results in 80% of biopsies. 9 However, in some cases the implant failed and only fibrous tissue was produced.
During the in vitro monolayer expansion, the cells typically dedifferentiate to a fibroblastic morphology and phenotype. 10 This is demonstrated by the production of type-I collagen as opposed to type-II collagen which is characteristic of hyaline cartilage. Dedifferentiation is reversible; the cells may regain their chondrocytic phenotype when cultured in conditions which induce a rounded morphology, such as agarose, 11 alginate [12] [13] [14] [15] or pellet culture. 16 Reexpression of a differentiated phenotype is enhanced by the presence of defined growth factors, such as TGF-β, insulin or IGF-I. 11, 12, 15 The culture conditions used for monolayer expansion may influence the response of the cells to the growth factors that are known to enhance the re-expression of the chondrogenic phenotype. [15] [16] [17] [18] [19] Despite the emergence of tissue-engineered strategies in clinical practice, there is still insufficient information regarding the influence of growth factors during the re-expression process associated with ACI. This study tests the hypothesis that a TGF-β1-containing defined culture medium enhances the reexpression of a chondrocytic phenotype and the subsequent production of cartilaginous extracellular matrix by human chondrocytes. In order to test the hypothesis, human monolayer expanded chondrocytes which were surplus to clinical requirements for ACI were maintained in pellet culture and exposed to TGF-β1 within a defined medium during culture for up to 14 days.
Methods and Materials
Assessment of cell number and viability. Chondrocytes were isolated from the medial femoral condyles of 24 patients with a mean age of 34 years (18 to 49), undergoing ACI. They were expanded in monolayer culture, using medium supplemented with autologous serum, for approximately four weeks. All the processing was performed by the supply laboratory of Verigen Transplantation Service International (Leverkeusen, Germany). Following expansion, the cell number and viability of a proportion of the cells from each patient was assessed at the supply laboratory using the trypan blue exclusion dye test. 20 Cells not required for the ACI procedures were then assessed for viability within an hour of the operative procedure. An estimation of cell number and viability was performed. Cells from four randomly selected patients were incubated for a further 16 hours at 4˚C prior to assessment using trypan blue.
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Preparation and maintenance of pellet cultures. Samples containing 4 x 10 5 cells were centrifuged at 500 g in 15 ml polypropylene conical tubes. 21 The supernatant was removed and the resultant pellet cultures were treated for 48 hours at 37˚C/5%CO 2 in a defined medium comprising of Dulbecco's Modified Eagles Medium, ITS+ Premix (Collaborative Biomedical Products: insulin (6.25 µg/ml), transferrin (6.25 µg/ml), selenous acid (6.25 µg/ml), bovine serum albumin (1.25 mg/ml), linoleic acid (5.35 µg/ml; BD Biosciences, Oxford, UK). Pyruvate (1 mM), dexamethasone (10 -7 M) and 10 ng/ml TGF-β1 (recombinant human, R&D Systems, Abingdon, UK) were also added. This medium is designated DMEM/ITS+/TGF-β1 hereafter.
After 48 hours the cells had formed pellets, which were randomly subdivided into two groups. One group was cultured further in DMEM/ITS+/TGF-β1 and the other was cultured in DMEM supplemented with 10% (v/v) foetal calf serum (FCS, Life Technologies, Paisley, UK). The medium was changed every two days and pellet cultures were removed at days 2, 7 and 14 for subsequent analysis. Biochemical analysis. Sulphated glycosaminoglycan (GAG) content in the samples was assessed using the 1,9-dimethylmethylene blue (DMB) technique as described by Farndale, Sayers and Barrett. 22 Briefly, cell pellets were removed from culture and digested by incubation for one hour at 60˚C in 0.5 ml papain digest buffer (Sodium citrate (55 mM), Sodium chloride (150 mM), Cysteine Hydrochloride (5 mM), EDTA (5 mM) (all Merck, Poole, UK)); and 1 µg/ml papain (Sigma, Poole, UK). A standard was prepared from chondroitin sulphate A obtained from bovine trachea (Sigma) and a standard curve was created using GAG concentrations from 0 to 50 µg/ml in 5 µg increments. A 96 well plate was used and 40 µl of both the standards and samples were pipetted into each well; 250 µl of DMB solution was added to each and the absorbance at 595 nm was determined using a microplate reader (Bio-Rad Ltd, Hemel Hempstead, UK).
The DNA content was determined using the Hoescht 33258 fluorometeric assay. 23 DNA from calf thymus (Sigma) was used to prepare a standard curve. Using a serial dilution technique the DNA standard concentrations of 20, 10, 5, 2.5, 1.25, 0.63, 0.31 and 0 µg/ml were prepared in SSC buffer. The samples were treated in papain digest buffer, as described above. A 100 µl aliquot of both the samples and standards was pipetted into a 96 well plate. Each standard concentration was used in triplicate. A 100 µl sample of Hoechst (1 µg/ml) was added to each of the wells. The samples were analysed using a microplate fluorimeter (Fluoroskan Ascent, LabSystems, Oxford, UK), with excitation set at 360 nm and emission monitored at 460 nm. Morphology and immunolocalisation. For histological and immunohistochemical analyses samples were fixed in 4% (w/v) paraformaldehyde in 0.1 M sodium cacodylate buffer at pH 7.4 for four hours. They were dehydrated sequentially in a series of graded alcohol washes, cleared in xylene prior to embedding in paraffin. For histological analysis 5 µm sections were prepared, deparaffinised, rehydrated by immersion in a sequence of xylene, 100% alcohol, 70% alcohol and finally water. The sections were stained with toluidine blue (1% in 50% isopropanol) or 1% Safranin-O. The streptavidin biotin-immunoperoxidase method was used for the immunolocalisation of collagen types I and II. Antibodies to collagen type-II (CIICI-Developmental Studies Hybridoma Bank, University of Iowa) and collagen type-I (Sigma) were used at dilutions of 1 in 100 and 1 in 500, respectively.
Sections were rehydrated and incubated in 200 µL hydrogen peroxide in 12 ml methanol to block the activity of endogenous peroxidase and then pre-treated in 0.1% (w/v) trypsin (Sigma), 0.1% (w/v) CaCl 2 in distilled H 2 O at 37˚C for ten minutes. After pre-treatment the sections were washed in tap water for ten minutes and soaked in Tris buffered saline (TBS; 0.05 M Tris, 0.15 M NaC, pH 7.6) for ten minutes. In order to suppress non-specific binding of IgG, the sections were blocked with normal rabbit serum (Dako A/S, Denmark), diluted 1:5 in TBS for 20 minutes. The sections were subsequently incubated with the selected primary antibody for 30 minutes at room temperature. The sections were washed with TBS for five minutes and biotinylated rabbit anti-mouse secondary antibody (Dako A/S, Denmark) was applied. Sections were incubated at room temperature for 30 minutes and then rinsed with TBS.
Streptavidin-Biotin complex (Dako A/S) was applied for 30 minutes, followed by a substrate solution containing 0.7 mg/mL -1 3', 3'-diaminobenzidine tetrahydrochloride, 0.7 mg/nL -1 urea hydrogen peroxide and Tris buffer 0.06 M (Sigma). The sections were counterstained with Harris's haematoxylin, washed in tap water, differentiated in acid alcohol and mounted.
Samples for transmission electron microscopy were fixed in 0.2% (w/v) glutaraldehyde in 4% (w/v) paraformaldehyde fixative, in a 0.1 M sodium cacodylate buffer at pH 7.2 for several hours. After initial fixation the tissue samples were stored in a 0.1 M sodium cacodylate buffer containing 0.1 M EDTA until processing. The samples were subsequently fixed using 1% osmium tetroxide in 0.1 M sodium cacodylate for 60 minutes, washed in 0.1 M sodium cacodylate followed by dehydration through a series of ethyl alcohols (70%, 80%, 90%, 96%, 100%) and infiltrated with several changes of Spurrs' resin. The specimens were placed into embedding moulds and cured for 18 hours at 70˚C. After polymerisation, 1 µm sections were cut on a LKB Ultratome III (LKB, Stockholm, Sweden) and stained with 1% toluidine blue in 1% Borax and viewed under an Olympus BH-2 light microscope. The areas of interest, which included a representative section displaying both cells and matrix, were selected. Resin blocks were further trimmed after which 90 nm sections for TEM were cut with a LKB Ultratome III ultramicrotome using a diamond knife. Sections were picked up onto copper grids, stained with 2% uranyl acetate and lead citrate and viewed on a Philips CM12 Electron Microscope at 80 kV. Statistical analysis. At each timepoint three replicate samples were analysed providing a total of nine replicate values from three separate experiments. Differences between the values obtained for each culture medium were analysed using the unpaired Student's t-test. Values of p < 0.05 were considered to indicate a statistical level of significance.
Results
Cell viability. The mean viabilities (±SEM) were 95.15 ± 0.49% and 95.80 ± 0.47% for the test (n = 24) and supply (n = 20) laboratories respectively. These differences were not statistically significant (p > 0.05). However, for the four batches of cells, which were incubated overnight at 4˚C, the corresponding viability assessed at the test laboratory had reduced to 60 ± 0.01%. The pellet model. Rounded pellets had formed in all of the cells cultured in DMEM/ITS+/TGF-β1, within 48 hours. By day seven, the pellets cultured in the DMEM/ITS+/TGF-β1 group were noticeably larger than the corresponding pellets cultured in the DMEM/10%FCS group. These differences remained apparent by day 14. Biochemical analysis. Figure 1 illustrates total DNA (Fig.  1a) and GAG (Fig. 1b) for pellets cultured for two days in DMEM/ITS+/TGF-β1 and for up to 12 days in either DMEM/ITS+/TGF-β1 or DMEM/10%FCS. DNA levels remained fairly static in pellets cultured in DMEM/ 10%FCS, but increased throughout the culture period for pellets cultured in DMEM/ITS+/TGF-β1. Accordingly DNA values were significantly greater at day 14 for pellets maintained in DMEM/ITS+/TGF-β1 compared with DMEM/10%FCS (p < 0.05). A slight reduction in GAG content was observed during 12 days culture in DMEM/ 10%FCS. By contrast, GAG levels increased markedly within pellets cultured for 12 days in DMEM/ITS+/TGF-β1. The mean GAG value of the DMEM/ITS+/TGF-β1 was significantly greater than the corresponding value for the DMEM/10%FCS group at days 7 and 14 (p < 0.05). Morphology and immunolocalisation. Standard histology confirmed that cells cultured in DMEM/ITS+/TGF-β1 generated larger pellets than those maintained in DMEM/ 10%FCS (Figs 2 to 4) . The cells cultured in DMEM/ 10%FCS were associated with reduced extracellular matrix, as indicated by toluidine blue staining, when compared with pellets maintained in DMEM/ITS+/TGF-β1, which stained metachromatically (Fig. 2b) . Immunolocalisation showed extensive staining for type-II collagen in pellets cultured in DMEM/ITS+/TGF-β1 (Fig. 3b) . By contrast, limited type-II collagen staining was apparent in the pellets maintained in DMEM/10%FCS (Fig. 3a) . The converse was observed for type-I collagen immunolocalisation, with positive staining evident within pellets maintained in DMEM/10%FCS (Fig. 4a ), yet minimal staining observed in the pellets cultured in DMEM/ITS+/TGF-β1 (Fig. 4b) .
Electron microscopy of the pellets showed obvious cytoarchitectural differences between the two groups. The pellets cultured in DMEM/10%FCS were highly compacted without any obvious spacious matrix (Fig. 5a) .
Within the cells clusters of lipid filled vacuoles were apparent and there was limited evidence of collagen fibrils within the pericellular region (Fig. 5a) . By contrast, abundant matrix and collagen fibrils were observed in the pericellular region of pellets cultured in DMEM/ITS+/TGF-β1 (Figs 5b  and c) .
Discussion
This study tests the hypothesis that a defined culture medium containing TGF-β1 enhances the re-expression of a chondrocytic phenotype and the subsequent production of cartilaginous extracellular matrix by human chondrocytes used in ACI. This study represents the first independent Photomicrographs of pellet cultures prepared using human monolayer-expanded chondrocytes. The pellets were cultured for two days in DMEM/ ITS+/TGF-β1 and subsequently maintained for 12 days in a) DMEM/10%FCS or b) DMEM/ITS+/TGF-β1 (toluidine blue staining, x132). Photomicrographs representing immunolocalisation for type-II collagen from pellet cultures prepared using human monolayer-expanded chondrocytes. The pellets were cultured for two days in DMEM/ITS+/TGF-β1 and subsequently maintained for 12 days in a) DMEM/10%FCS or b) DMEM/ ITS+/TGF-β1 (counterstained with Harris's haematoxylin, x132). Photomicrographs representing immunolocalisation for type-I collagen from pellet cultures prepared using human monolayer-expanded chondrocytes. The pellets were cultured for two days in DMEM/ITS+/TGF-β1 and subsequently maintained for 12 days in a) DMEM/10%FCS or b) DMEM/ ITS+/TGF-β1 (counterstained with Harris's haematoxylin, x132). Electron micrographs of pellet cultures prepared using human monolayer-expanded chondrocytes. The pellets were cultured for two days in DMEM/ITS+/TGF-b1 and subsequently maintained for 12 days in a) DMEM/10%FCS (x6000) or b) DMEM/ITS+/TGF-b1 (x6000). Figure 5c is taken from the bottom right hand corner of Figure 5b (x26000). This indicates the presence of collagen fibrils in the extracellular matrix (arrow).
audit of the numbers, and viability, of the cells which are intended for implantation into cartilage defects of patients. Our results indicated a consistent pellet formation and redifferentiation of the cells cultured in DMEM/ITS+/TGF-β1 medium. In a separate experiment it was found that cells initially cultured in DMEM/10%FCS failed to form pellets, despite the presence of serum-derived adhesion factors within the medium, indicating the importance of the growth factor environment on the ability of cells to form pellets. For this reason all cells were exposed to the DMEM/ITS+/TGF-β1 medium initially until pellets were formed. However, it was also found that if the cells in monolayer were cultured in medium supplemented with FCS for one further passage then the cells would subsequently form pellets in the DMEM/10%FCS medium. These data support the proposition of Jakob et al 16 that the conditions of expansion of human articular chondrocytes can modulate their ability to re-enter the differentiation programme when transferred to a three-dimensional environment. The expression of specific adhesion molecules or surface markers may be altered by the culture conditions used during monolayer expansion. 24 The repair of chondral defects using ACI techniques requires the proliferation of cells and the elaboration of a GAG-rich extracellular matrix. It is important to note, in addition to the alteration in the expression of phenotypic markers, that pellets cultured in DMEM/ITS+/TGF-β1 were larger with greater amounts of DNA and GAG compared with pellets maintained in DMEM/10%FCS. DNA values increased by 80% from days 2 to 14, suggesting that DMEM/ITS+/TGF-β1 has a mitogenic effect on the monolayer expanded human cells. This level of proliferation is broadly similar to that reported previously for primary human chondrocytes cultured in alginate beads over a fourweek period. 25 GAG synthesis was stimulated within pellets cultured in DMEM/ITS+/TGF-β1, as indicated by a 107% increase in GAG levels between days 2 and 14. By contrast GAG levels were reduced by 25% over the same period for pellets maintained in DMEM/10%FCS. Histology and electron microscopy confirm these findings, indicating that pellets maintained in DMEM/ITS+/TGF-β1 possessed an extensive extracellular matrix (Fig. 2b) , containing clearly defined collagen fibrils (Figs 5b and 5c) . Conversely, pellets maintained in DMEM/10%FCS possessed limited extracellular matrix (Fig. 2a) and the cells were small, approximately 10 µm in diameter, and laden with lipid filled vacuoles (Fig. 5a ), suggesting that they were less active than those cultured in DMEM/ITS+/TGF-β1.
In our present study the cells were expanded in monolayer using culture medium supplemented with autologous serum. Brittberg et al's 8 original description of the ACI technique on 23 patients also used autologous serum during monolayer culture. This practice however, has not subsequently been standardised in clinical use, where supplementation with either autologous serum or foetal calf serum are employed by different companies supplying the cells, and this could have important clinical consequences.
Our study confirms that a defined medium containing TGF-β1 induces the re-expression of a chondrocytic phenotype and the subsequent stimulation of GAG and type-II collagen production by human monolayer expanded chondrocytes. Accordingly, TGF-β1 may be necessary for the formation of cellular aggregates, the initiation of cell proliferation and the development of a hyaline cartilage matrix within a clinical repair situation. For procedures, which involve the seeding of cells onto a biomaterial membrane, such as MACI, the provision of a TGF-β containing defined medium during the culture phase prior to implantation is recommended.
